Cabané P, Gac P, Amat J, Pineda P, Rossi R, Caviedes R, Caviedes P
Endocrine Surgery, University of Chile-Clinical Hospital, Santiago, Chile.
Transplant Proc. 2009 Nov;41(9):3879-83. doi: 10.1016/j.transproceed.2009.06.211.
The last therapeutic alternative in severe postsurgical hypoparathyroidism is allotransplantation of microencapsulated parathyroid cells. With this technique, it is possible to implant cells or tissue of parathyroid origin to replace them in such patients, without immusupression. We report an allotransplant of parathyroid tissue in a patient with continous endovenous requirement of calcium to survive. The microencapsulation was carried out with a commercial sodium alginate. We implant 23 microspheres in the nondominant forearm and 40 microspheres in the leg in a second attempt. In this article, we show functionality of the graft for at least 20 months without requirement of endovenous calcium. We report this procedure as a therapeutical alternative in severe hypoparathyroidism.
严重术后甲状旁腺功能减退的最后一种治疗选择是微囊化甲状旁腺细胞的同种异体移植。通过这种技术,可以植入甲状旁腺来源的细胞或组织来替代此类患者的甲状旁腺,而无需免疫抑制。我们报告了一例甲状旁腺组织同种异体移植病例,该患者持续需要静脉补钙以维持生命。微囊化采用市售海藻酸钠进行。我们首次在前臂非优势侧植入23个微球,第二次尝试在腿部植入40个微球。在本文中,我们展示了移植物至少20个月的功能,无需静脉补钙。我们将此手术报告为严重甲状旁腺功能减退的一种治疗选择。